Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

FDA authorizes Pfizer’s Covid booster shots for Americans deemed “most at risk”

Chidinma AnyalewechibyChidinma Anyalewechi
1 year ago
in Coronavirus
International Organizations, Vaccine manufacturers strategize to achieve vaccination threshold

Vaccination

Share on FacebookShare on TwitterShare on Linkedin

The Food and Drug Administration, on Wednesday, authorized booster shots of Pfizer and BioNTech’s Covid-19 for people who are 65 years and older and other vulnerable and immunocompromised citizens six months after they complete their first two doses.

This new move was as a result of the vaccine advisory committee recommendations on Friday, after more than an eight-hour agency meeting.

This decision still faces review by the Centers for Disease Control and prevention and its vaccine advisory committee is expected to vote this afternoon on the FDA’s proposal. Upon recommendation of approval, if the CDC endorses it, booster shots could commence immediately.

The FDA’s Vaccines Advisory Committee, last week, agreed unanimously to give boosters to older Americans and those who are highly vulnerable and are at high risk of suffering from severe illness should they contract the virus.

This came after a 16-2 vote against distributing the vaccines to Americans 16 and older.

The committee’s decision was informed by the vulnerability of people who fall under that classification as they are the most at risk of dying from Covid, accounting for more than 77% of all Covid deaths, according to the CDC, although these brackets make up roughly 17% of the U.S. population.

Emergency use authorization has been granted by the FDA for the administration of Pfizer’s shots to older Americans as well as to people aged 18 to 64 with medical conditions which makes them vulnerable and places them at risk of getting severely sick.

In addition, the agency included a broad definition of people from 18 to 64 “whose frequent institutional or occupational exposure” to the virus place them at a high risk of developing serious complications from Covid.

There’s a likelihood that the CDC would clear third doses for people working in nursing homes, prisons, front-line health employees and other essential workers who were amongst the first Americans to get the initial shots in December.

According to the agency’s top vaccine regulator, Dr. Peter Marks, “The FDA considered the committee’s input and conducted its own thorough review of the submitted data to reach today’s decision”.

“We will continue to analyze data submitted to the FDA pertaining to the use of booster doses of COVID-19 vaccines and we will make further decisions as appropriate based on the data.” he added.

Recall that, the Biden administration has said it wants to begin offering booster shots to the general public as early as this week, pending authorization from U.S. health regulators, hence the decision by the vaccine advisory committee is expected to be controversial.

Related

Tags: BioNTechCovid-19 booster shotsFDAFood and Drug AdministrationPfizer

Comments 1

  1. Lawan yunusa says:
    September 23, 2021 at 4:57 pm

    I didn’t get a corvic19 upto now

    Reply

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Just in: Emefiele insists the CBN is not considering extending deadline for swapping naira notes
  • Traction Launches Business Solution Suite, Grow with Traction To Support MSMEs
  • FG says Apongbon Brdige will be reopened to traffic in May

Follow us on social media:

Recent News

CBN embarks on unconventional moves to beat January 31 deadline

Just in: Emefiele insists the CBN is not considering extending deadline for swapping naira notes

February 3, 2023
Traction Launches Business Solution Suite, Grow with Traction To Support MSMEs

Traction Launches Business Solution Suite, Grow with Traction To Support MSMEs

February 3, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics